FundedIQ
Biotechnology

CRISP-HR Therapeutics: Funding, Investors & Team (Oct 2026)

CRISP-HR, we have developed the next great leap in gene-editing technology and CRISPR therapeutics – The Cas9-HR Platform.

www.crisp-hr.com LinkedIn San Carlos, United States 1-10 employees
Biotechnology Life Science Therapeutics
Total raised
$100k
Rounds
1
Latest
Non-equity Assistance
Mar 2022

CRISP-HR Therapeutics has raised $100k across 1 funding round on record, the most recent a Non-equity Assistance of $100k announced in Mar 2022.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

CRISP-HR Therapeutics Company Profile and Key Stats

Total funding raised
$100k
across 1 round on record
Funding rounds on record
1
Latest funding round
Non-equity Assistance
$100k in Mar 2022
Employees
1-10
reported band
Headquarters
San Carlos, United States

Latest funding round on record: Mar 2022.

CRISP-HR Therapeutics Funding Rounds

Date
Round
Amount
Non-equity Assistance
$100k

CRISP-HR Therapeutics Founders and Leadership Team

Name
Role
Contact
Chris Hackley
CEO
Locked

Contact details for the CRISP-HR Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

CRISP-HR Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round

CRISP-HR Therapeutics' latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like CRISP-HR Therapeutics in Biotechnology and San Carlos

Companies Similar to CRISP-HR Therapeutics

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

CRISP-HR Therapeutics Funding FAQs

What does CRISP-HR Therapeutics do?

CRISP-HR, we have developed the next great leap in gene-editing technology and CRISPR therapeutics – The Cas9-HR Platform.

How much funding has CRISP-HR Therapeutics raised?

CRISP-HR Therapeutics has raised $100k across 1 round on record. The most recent is a Non-equity Assistance of $100k announced in Mar 2022.

When did CRISP-HR Therapeutics last raise funding?

CRISP-HR Therapeutics' most recent funding round on record is a Non-equity Assistance of $100k, announced in Mar 2022.

Who is the CEO of CRISP-HR Therapeutics?

Chris Hackley is listed as CEO at CRISP-HR Therapeutics.

Where is CRISP-HR Therapeutics headquartered?

CRISP-HR Therapeutics is based in San Carlos, California, United States.

How many employees does CRISP-HR Therapeutics have?

CRISP-HR Therapeutics is in the 1-10 employee band.

How does CRISP-HR Therapeutics' funding compare to other Biotechnology startups?

CRISP-HR Therapeutics' latest round of $100k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's CRISP-HR Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CRISP-HR Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.